ArticleAmerican journal of cardiovascular disease2025
Obesity paradox in atrial fibrillation and flutter: a multivariate nationwide inpatient analysis.
Article in American journal of cardiovascular disease, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesAtrial Fibrillation and atrial flutter (Afib/Aflut) are the most common arrhythmias that present in the emergency department. This study aimed to evaluate in-hospital mortality based on weight categories in patients with Afib/flut.
methodsUsing ICD-10 codes from the large Nationwide Inpatient Sample (NIS) database in the years 2016-2020, we evaluated any association between the presence of Afib/Aflut and mortality in different weight categories in adults over the age of 18.
resultsA total of 23,037,013 Afib/flut patients were found in the NIS database. Total mortality in patients with Afib/Aflut was 5.03%. Mortality in patients with normal weight was 5.26%. Mortality was lowest in overweight (2.3%) followed by Obesity (2.97%) and morbid obesity (2.97%). It was highest in cachectic patients (15.89%), all
conclusionsThe obesity paradox is present in patients admitted to the hospital with Afib/Aflut. Regardless of comorbid conditions or demographics, the lowest mortality was seen in overweight patients. Furthermore, the COVID-19 pandemic year independently increased inpatient mortality from Afib/Aflut.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.